Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

52.41
+0.45000.87%
Post-market: 52.420.0100+0.02%19:59 EDT
Volume:2.40M
Turnover:125.62M
Market Cap:106.01B
PE:16.76
High:52.57
Open:51.35
Low:51.35
Close:51.96
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.71
T/O Rate:0.12%
Dividend:1.77
Dividend Rate:3.38%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.40
PE(LYR):14.03

Loading ...

Movement Alert|GSK Rises 3.02% in Regular Trading, Pharma Sector Rallies as Nuvalent Tender Offer Advances

Market Focus
·
Jul 02

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Jul 02

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

TIPRANKS
·
Jul 01

GSK: Neutral Stance Maintained as Near-Term Strength Offsets Pipeline and Litigation Risks; Price Target Held at £2,350

TIPRANKS
·
Jun 30

Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 30

GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights

TIPRANKS
·
Jun 29

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 29

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 29

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

TIPRANKS
·
Jun 27

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

TIPRANKS
·
Jun 26

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

TIPRANKS
·
Jun 26

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

TIPRANKS
·
Jun 26

GSK Rallies Thursday, Outperforms Market

Dow Jones
·
Jun 26

GSK to Deliver Earnings Growth over Next Decade

Dow Jones
·
Jun 25

Gsk's HIV Franchise Seems Underappreciated

Dow Jones
·
Jun 25

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 25

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

TIPRANKS
·
Jun 25

GSK Unit Launches Tender Offer for Nuvalent Acquisition

MT Newswires Live
·
Jun 25

GSK Discloses Executive Notional ADS Acquisition by U.S. President

TIPRANKS
·
Jun 24

GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent

TIPRANKS
·
Jun 24